EyeTechCare
EyeTechCare developed the EyeOP1, an ultrasound device offering non-invasive treatments for refractory glaucoma.
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (3 %) | - | - | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (479 %) | - | - | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (538 %) | - | - | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Eye Tech Care specializes in the development and manufacturing of non-invasive medical devices for the treatment of glaucoma. Utilizing advanced focused ultrasound technology, their devices provide a quick, incision-free procedure that can be completed in just five minutes. This innovative approach allows for repeatable treatments, making it a long-term solution for glaucoma management. The company primarily serves ophthalmologists and healthcare providers who treat patients with glaucoma, a condition affecting millions worldwide. Operating in the medical device market, Eye Tech Care's business model revolves around the sale of their CE-marked class IIb medical devices to healthcare institutions. Revenue is generated through direct sales and partnerships with medical distributors. The company is headquartered in Rillieux-la-Pape, France, and is committed to addressing the global health burden of glaucoma, which is a leading cause of blindness.
Keywords: glaucoma, non-invasive, ultrasound, medical device, ophthalmology, CE-marked, healthcare, treatment, innovation, repeatable.